Renin-angiotensin-system acting agents market to reach $7.96 billion by 2030 at 5.4% CAGR, driven by increasing prevalence of hypertension.
Read More
Remicade biosimilar market to reach $13.31 billion by 2030 at 22.2% CAGR, driven by rising incidence of autoimmune diseases and growing healthcare expenditure.
Read More
Remdesivir market to reach $17.96 billion by 2030 at 12.6% CAGR, driven by increasing government expenditure, growing demand for clinical trials, and rising healthcare expenditure.
Read More
Regenerative medicine for cartilage market to reach $6.33 billion by 2030 at 6.3% CAGR, driven by increasing number of chronic diseases.
Read MoreRegenerative aesthetics market to reach $28.88 billion by 2030 at 13.1% CAGR, driven by rising need for minimally invasive procedures.
Read More
Raynauds disease treatment market to reach $2.13 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of autoimmune diseases and rising healthcare expenditure.
Read More
Rare kidney diseases market to reach $4.88 billion by 2030 at 10.2% CAGR, driven by increasing prevalence of chronic kidney disease.
Read MoreRare gastrointestinal diseases treatment market to reach $1.91 billion by 2030 at 5.6% CAGR, driven by rising diagnostic testing.
Read More
Rare epilepsy syndromes therapeutics market to reach $3.38 billion by 2030 at 8.4% CAGR, driven by increasing prevalence of rare diseases.
Read MoreRare diseases treatment market to reach $386.69 billion by 2030 at 12.6% CAGR, driven by increasing burden of rare diseases.
Read More